NCT03286023|UnknownDMC
Stereotactic Radiotherapy for Brain Metastases
CKBrainMeta
Loading search results
CKBrainMeta
Sponsor study identifier
observational
110
1 country
1
Study Start
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2019
Actual (reported)Study Completion
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
September 7, 2017
Actual (reported)September 18, 2017
Actual (reported)October 2019
Actual (reported)December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Evaluation of tumoral response
Evaluation of response using Magnetic resonance imaging (Recist criteria)
4 weeks after treatment
Evaluation of tumoral response
Evaluation of response using Magnetic resonance imaging (Recist criteria)
8 weeks after treatment
Evaluation of toxicity
1, 3, 6, 9, 12, 15 months after treatment
Stereotactic radiation for brain metastases
stereotactic radiotherapy for brain metastases
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with brain metastases
Centre Francois Baclesse
Esch-sur-Alzette, SUD, L-4240, Luxembourg
110 participants (actual enrollment reported by the registry).
First Submitted
September 7, 2017
First Posted
September 18, 2017
Study Start
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
October 2019
Actual (reported)Study Completion
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 22, 2022
Record last verified: 2022-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: